XML 57 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investment in Subsidiaries - Additional Information (Detail) (USD $)
9 Months Ended 12 Months Ended 9 Months Ended
Jun. 30, 2014
Jun. 30, 2014
Calando Pharmaceuticals Inc
Sep. 30, 2011
Ablaris Therapeutics
Jun. 30, 2014
Ablaris Therapeutics
Jun. 30, 2014
Leonardo Biosystems Inc
Schedule Of Investments [Line Items]          
Ownership percentage in subsidiary 100.00%       3.00%
Outstanding Balance of Promissory Note   $ 1,253,000      
Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount   87,000      
Amount owed by subsidiary   4,500,000      
Stated percentage of notes and advances   8.00%      
Percentage of outstanding shares   79.00%   64.00%  
Percentage of investment ownership   76.00%   64.00%  
Issuance of preferred stock in subsidiary     2,900,000    
Investment in preferred stock     1,300,000    
Investment in preferred stock by outsider     $ 1,600,000